Gyermekkori daganatok: vizsgálatok itt: Kína
611 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleThe Safety and Efficacy of Cetuximab Beta Plus Fruquintinib With or Without Immune Checkpoint Inhibitorrs in First-line Treatment of RAS/BRAF Wild Type Unresectable Metastatic Colorectal Cancer
- Where
- Hangzhou
- Életkor
- 10 év to 85 év
- People
- 70
- Run by
- Zhejiang University
See details and how to joinNCT07257653 - No phaseTaking peopleDevelopment and Prospective Validation of a Digital Pathology-based Artificial Intelligence Diagnostic Model for Pan-cancer Lymphatic Metastasis
- Where
- Guangzhou
- People
- 10 000
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06517979 - 1/2. fázisTaking peopleAutologous and Donor-derived CD7 CAR-T Therapy in Refractory or Relapsed T-cell Malignancies
- Where
- Beijing, Chengdu, Shanghai
- Életkor
- 1 év to 70 év
- People
- 80
- Run by
- Beijing GoBroad Hospital
See details and how to joinNCT06316427 - 1/2. fázisTaking peopleA Multicenter, Open-Label, Non-Randomized, Single-Arm Clinical Study of Nanobody CD5-CAR T Cell Therapy for Refractory/Relapsed T Lymphocyte Malignancies
- Where
- Beijing, Chengdu, Shanghai
- Életkor
- 1 év to 70 év
- People
- 54
- Run by
- Beijing GoBroad Hospital
See details and how to joinNCT07070323 - No phaseTaking peopleMR Microstructural Imaging for Prostate Cancer Diagnosis
- Where
- Beijing, Dalian, Hangzhou, Nanjing, Zhengzhou
- People
- 2000
- Run by
- First Affiliated Hospital of Zhejiang University
See details and how to joinNCT07249281 - 2. fázisTaking peopleAssessment of Senl_B19 CAR-T Cells in Relapsed/Refractory CD19+ B-ALL
- Where
- Beijing
- Életkor
- 3 év to 25 év
- People
- 59
- Run by
- Hebei Senlang Biotechnology Inc., Ltd.
See details and how to joinNCT07244406 - 2. fázisTaking peopleInotuzumab Ozogamicin in the Treatment of MRD+ After HSCT of ALL
- Where
- Suzhou
- Életkor
- 15 év to 65 év
- People
- 42
- Run by
- Sheng-Li Xue, MD
See details and how to joinNCT05940961 - 1. fázisTaking peopleBlinatumomab and Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-ALL
- Where
- Suzhou
- Életkor
- 15 év to 65 év
- People
- 4
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT06507514 - No phaseTaking peopleZanubrutinib Combined With Rituximab in the Treatment for Patients With Marginal Zone Lymphoma
- Where
- Zhengzhou
- People
- 30
- Run by
- Henan Cancer Hospital
See details and how to joinNCT07233720 - 2. fázisTaking peoplePhase II, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of HLX43 (an Anti-PD-L1 ADC) in Subjects With Advanced Colorectal Cancer
- Where
- Beijing, Jinan
- Életkor
- 18 nap to 75 nap
- People
- 60
- Run by
- Shanghai Henlius Biotech
See details and how to joinNCT07106892 - No phaseTaking peopleID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
- Where
- Beijing
- People
- 2000 worldwide
- Run by
- Stanford University
See details and how to joinNCT02848274 - 4. fázisTaking peopleOndansetron Orodispersible Film for Vomiting Prevention in Pediatric Radiotherapy
- Where
- Chongqing
- Életkor
- 1 év to 14 év
- People
- 60
- Run by
- Chongqing University Cancer Hospital
See details and how to joinNCT07217600 - No phaseTaking peopleHigh-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)
- Where
- Xining
- People
- 1000
- Run by
- Yigeng Cao,MD,PhD
See details and how to joinNCT07205523 - 2. fázisTaking peopleVebreltinib for Advanced or Metastatic CCS
- Where
- Hangzhou
- Életkor
- 12 év and over
- People
- 30
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07153887 - No phaseNot yet taking people in KínaA Real-World Study of IBI351 for KRAS G12C+ NSCLC in China
- Where
- Guangzhou
- People
- 600
- Run by
- Guangdong Association of Clinical Trials
See details and how to joinNCT07198620 - 2. fázisTaking peopleOrelabrutinib and Rituximab With Optional Autologous Hematopoietic Stem Cell Transplantation in MCL Treatment
- Where
- Shanghai
- Életkor
- 14 év and over
- People
- 45
- Run by
- Ruijin Hospital
See details and how to joinNCT07199296 - No phaseTaking peopleClinical Application of Somatostatin Receptor and Norepinephrine Transporter Targeted Imaging for Diagnosis and Staging of Neuroblastoma and Pheochromocytoma/Paraganglioma
- Where
- Nanjing
- Életkor
- 6 hónap and over
- People
- 30
- Run by
- Nanjing First Hospital, Nanjing Medical University
See details and how to joinNCT07195500 - No phaseTaking peopleA Clinical Study on the Efficacy and Safety of Methotrexate (MTX) or Thiotepa (for MTX Intolerance) or Temozolomide (TMZ) Combined With Orelabrutinib and Selinexor in Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma(SELINA)
- Where
- Shanghai
- Életkor
- 14 év to 80 év
- People
- 25
- Run by
- Ruijin Hospital
See details and how to joinNCT07191431 - No phaseTaking peoplePucotenlimab Combined With Lenvatinib and Chemotherapy in the Treatment of Advanced, Relapsed/Refractory Hepatoblastoma in Children
- Where
- Guangdong
- Életkor
- 2 év to 18 év
- People
- 24
- Run by
- Sun Yat-sen University
See details and how to joinNCT07188311 - 2. fázisTaking peopleTreatment of Newly Diagnosed Central Malignant Germ Cell Tumor People With Teniposide Injection Combined With Cisplatin.
- Where
- Guangzhou
- Életkor
- 5 év and over
- People
- 40
- Run by
- Chengcheng Guo
See details and how to joinNCT07188441 - No phaseTaking peopleMulticentric Database for Solid Pseudopapillary Neoplasm of the Pancreas
- Where
- Shanghai
- People
- 2000
- Run by
- Fudan University
See details and how to joinNCT07183280 - No phaseTaking peopleDisitamab Vedotin (RC48-ADC) in Breast Cancer
- Where
- Shanghai
- People
- 45
- Run by
- RenJi Hospital
See details and how to joinNCT05851677 - No phaseTaking peopleImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma Patients
- Where
- Beijing
- Életkor
- 14 év to 80 év
- People
- 20
- Run by
- Deling Li
See details and how to joinNCT07177482 - 1. fázisTaking peopleBCMA-CD19 cCAR in Multiple Myeloma and Plasmacytoid Lymphoma
- Where
- Chengdu, Shenzhen
- People
- 12
- Run by
- iCell Gene Therapeutics
See details and how to joinNCT04162353 - No phaseNot yet taking people in KínaRisk-adapted Therapeutic Strategy in +1q NDMM
- Where
- Changchun
- People
- 200
- Run by
- FengYan Jin
See details and how to joinNCT07045168